CHERI CARMODY: Open Payments
NPI 1467453134 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 19 payments from 7 companies in 2025. Trend: 2023 $914 · 2024 $781 · 2025 $766
Food & beverage: $681Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $209 |
| CONMED Corporation | 2 | $139 |
| Janssen Biotech, Inc. | 3 | $131 |
| Ardelyx, Inc. | 1 | $115 |
| Aimmune Therapeutics, Inc. | 5 | $100 |
| ABBVIE INC. | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: DUPIXENT, TREMFYA, IBSRELA, CONMED HEMOSTASIS, ZENPEP, CONMED BILIARY, VOWST, SKYRIZI.
Industry payments across MO — which companies pay providers there.
